WallStreetZenWallStreetZen

NASDAQ: URGN
Urogen Pharma Ltd Stock Ownership - Who owns Urogen Pharma?

Insider buying vs selling

Have Urogen Pharma Ltd insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Mark SchoenbergChief Medical Officer2024-06-105,153$13.08
$67.40kSell
Mark SchoenbergChief Medical Officer2024-03-1812,000$14.05
$168.60kSell
Jason Drew SmithGeneral Counsel2024-02-01417$15.78
$6.58kSell
Mark SchoenbergChief Medical Officer2024-02-011,894$15.78
$29.89kSell
Mark SchoenbergChief Medical Officer2024-02-01758$15.78
$11.96kSell
Mark SchoenbergChief Medical Officer2024-02-011,137$15.78
$17.94kSell
Jason Drew SmithGeneral Counsel2024-02-013,328$15.78
$52.52kSell
Jason Drew SmithGeneral Counsel2024-02-011,248$15.78
$19.69kSell
Jason Drew SmithGeneral Counsel2024-01-311,248$15.74
$19.64kSell
Mark SchoenbergChief Medical Officer2024-01-311,137$15.74
$17.90kSell

1 of 3

URGN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when URGN insiders and whales buy or sell their stock.

URGN Shareholders

What type of owners hold Urogen Pharma Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ran Nussbaum21.24%7,674,072$118.72MInsider
Rtw Investments LP9.02%3,257,347$50.39MInstitution
Ra Capital Management LP8.53%3,083,430$47.70MInstitution
Great Point Partners LLC7.25%2,620,545$40.54MInstitution
Menora Mivtachim Holdings Ltd6.37%2,303,031$35.63MInstitution
Blackrock Inc4.75%1,716,813$26.56MInstitution
Cowen And Company LLC4.50%1,626,589$25.16MInstitution
Adage Capital Partners GP LLC3.60%1,300,000$20.11MInstitution
Proquest Investments Iv LP3.44%1,242,031$19.21MInsider
Credit Suisse Ag 13.32%1,200,000$18.56MInstitution

1 of 3

URGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
URGN73.07%26.93%Net BuyingNet Selling
ABUS25.79%74.21%Net Selling
AVBP65.24%31.26%Net Buying
PHAR0.00%0.00%
MREO11.98%4.59%Net BuyingNet Buying

Urogen Pharma Stock Ownership FAQ

Who owns Urogen Pharma?

Urogen Pharma (NASDAQ: URGN) is owned by 75.18% institutional shareholders, 27.71% Urogen Pharma insiders, and 0.00% retail investors. Ran Nussbaum is the largest individual Urogen Pharma shareholder, owning 7.67M shares representing 21.24% of the company. Ran Nussbaum's Urogen Pharma shares are currently valued at $118.72M.

If you're new to stock investing, here's how to buy Urogen Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.